Tune in to this recording from a live satellite symposium offered in conjunction with the Society for Immunotherapy of Cancer (SITC) 2024 meeting. Discover new insights as two esteemed oncologists examine groundbreaking treatment advances in cancer vaccines, focusing on emerging evidence and mechanisms of action behind novel immune-modulating therapeutic cancer vaccines, including recent clinical data in advanced melanoma. Discover how these innovative treatments are poised to transform the treatment paradigm, offering new options for patients with cancer. Hear expert insights on clinical implications of emerging evidence, including patient eligibility, treatment selection, and considerations for integration of novel cancer vaccines into clinical practice. Don’t miss this unique opportunity explore the potential of these novel treatment approaches to improve health outcomes for patients with advanced melanoma and other cancers. This activity is delivered in partnership with the Melanoma Research Alliance.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/amplifying-latest-evidence-cancer-vaccines-improve-patients-outcomes-advanced
- Start Date: 2024-12-06 06:00:00
- End Date: 2024-12-06 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: IO Biotech, Inc - Amount: 125000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all